Dr. Reddy's Laboratories shares in Friday's trade slipped by over 6 per cent in early trade to the day's low price of Rs 1,203.6 after the pharma major posted weak performance during the December ...

Cyient is grappling with multiple challenges, including disappointing Q3 results, a downward revision in FY25 growth guidance, and the CEO's resignation, all of which have dampened investor sentiment.